Federal Industry Fee accuses 3 drug middlemen of inflating insulin costs
The Federal Industry Fee mentioned Friday that it’s suing 3 drug middlemen, accusing them of inflating insulin costs.The FTC accused the “Large 3” pharmacy get advantages managers (PBMs) — UnitedHealth Team’s Optum